Brands2Life launches Pharma Tech offer with the appointment of Isabelle Scali as Head of Pharma

London, UK – 18 September 2024 – Brands2Life is delighted to announce the appointment of Isabelle Scali as Head of Pharma, a newly created senior role within its expanding Health practice.

Isabelle’s appointment comes as Brands2Life launches a new pharma technology service, designed to help pharmaceutical companies navigate the growing intersection of health and technology, bringing a more agile and creative approach to healthcare communications.

Isabelle will play a pivotal role in spearheading Brands2Life’s mission to support the most ambitious and innovative healthcare brands across the UK and US. Her appointment comes at a time when pharmaceutical companies are embracing technology to accelerate drug development, deliver personalised care and achieve enhanced patient outcomes.

With over 20 years of experience in healthcare and pharma communications – both in agencies and in-house – Isabelle brings with her an impressive track record of success. She spent a decade leading global corporate communications at ViiV Healthcare, where she was instrumental in rebranding efforts and managing the company’s reputation on a global scale.

Known for her bold, creative approach to strategic health communications, Isabelle will now join Brands2Life’s Senior Leadership Team and report directly to Emily Thomas, Managing Director, Health.

Commenting on the appointment, Emily Thomas said, “We are thrilled to welcome Isabelle to the team at such an exciting time for health communications. As we continue to explore new ways to harness technological innovation in the pharma sector, Isabelle’s vision, energy and deep expertise will help us push the boundaries of what’s possible and deliver transformative communications strategies.”

Isabelle added, “With the pharma sector embedding technology across all aspects of their business, I am excited to bring my creative spirit and industry expertise together with Brands2Life’s heritage in health and tech. We are here to help clients elevate their brands and take a bolder approach to communications in a landscape where technology is changing the expectations of clinicians and patients.”

Brands2Life Health launched six years ago and counts ambitious AI, digital health, biotech, pharma and consumer health companies amongst its clients, including Bayer, CellVoyant, CooperVision, Hologic, Sanofi and 23andMe.